Free Trial

Crescent Capital BDC (CCAP) Competitors

Crescent Capital BDC logo
$19.34 -0.02 (-0.10%)
As of 01/17/2025 04:00 PM Eastern

CCAP vs. ADX, PTY, USA, RVT, OXLC, BCAT, GAB, STEW, GSBD, and CET

Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), Liberty All-Star Equity Fund (USA), Royce Value Trust (RVT), Oxford Lane Capital (OXLC), BlackRock Capital Allocation Term Trust (BCAT), The Gabelli Equity Trust (GAB), SRH Total Return Fund (STEW), Goldman Sachs BDC (GSBD), and Central Securities (CET). These companies are all part of the "financial services" industry.

Crescent Capital BDC vs.

Adams Diversified Equity Fund (NYSE:ADX) and Crescent Capital BDC (NASDAQ:CCAP) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings.

In the previous week, Adams Diversified Equity Fund had 8 more articles in the media than Crescent Capital BDC. MarketBeat recorded 10 mentions for Adams Diversified Equity Fund and 2 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 1.59 beat Adams Diversified Equity Fund's score of 0.54 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adams Diversified Equity Fund
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Crescent Capital BDC
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Adams Diversified Equity Fund received 113 more outperform votes than Crescent Capital BDC when rated by MarketBeat users. However, 55.93% of users gave Crescent Capital BDC an outperform vote while only 53.09% of users gave Adams Diversified Equity Fund an outperform vote.

CompanyUnderperformOutperform
Adams Diversified Equity FundOutperform Votes
146
53.09%
Underperform Votes
129
46.91%
Crescent Capital BDCOutperform Votes
33
55.93%
Underperform Votes
26
44.07%

Crescent Capital BDC has higher revenue and earnings than Adams Diversified Equity Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adams Diversified Equity FundN/AN/AN/AN/AN/A
Crescent Capital BDC$184.13M3.89$83.84M$2.557.58

Adams Diversified Equity Fund has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

28.4% of Adams Diversified Equity Fund shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.1% of Adams Diversified Equity Fund shares are owned by company insiders. Comparatively, 1.1% of Crescent Capital BDC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Crescent Capital BDC has a net margin of 47.06% compared to Adams Diversified Equity Fund's net margin of 0.00%. Crescent Capital BDC's return on equity of 12.20% beat Adams Diversified Equity Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Adams Diversified Equity FundN/A N/A N/A
Crescent Capital BDC 47.06%12.20%5.57%

Crescent Capital BDC has a consensus price target of $19.17, suggesting a potential downside of 0.90%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Adams Diversified Equity Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adams Diversified Equity Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Crescent Capital BDC
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Adams Diversified Equity Fund pays an annual dividend of $2.50 per share and has a dividend yield of 11.9%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 8.7%. Crescent Capital BDC pays out 65.9% of its earnings in the form of a dividend.

Summary

Crescent Capital BDC beats Adams Diversified Equity Fund on 11 of the 16 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCNondepository credit institutions IndustryFinance SectorNASDAQ Exchange
Market Cap$716.74M$8.56B$11.78B$9.14B
Dividend Yield9.07%5.12%6.02%4.02%
P/E Ratio7.5819.4925.2417.36
Price / Sales3.8919.3128.3677.11
Price / Cash8.8748.1717.2635.97
Price / Book0.972.652.654.79
Net Income$83.84M$462.58M$1.04B$225.00M
7 Day Performance3.87%10.11%2.92%2.62%
1 Month Performance-0.92%7.35%0.91%3.81%
1 Year Performance16.93%51.61%14.70%20.10%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCAP
Crescent Capital BDC
2.8574 of 5 stars
$19.34
-0.1%
$19.17
-0.9%
+16.9%$716.74M$184.13M7.58N/APositive News
ADX
Adams Diversified Equity Fund
N/A$20.35
+0.6%
N/A+17.3%$2.52B$639.96M0.0030Dividend Cut
Short Interest ↓
News Coverage
PTY
PIMCO Corporate & Income Opportunity Fund
N/A$14.35
+0.5%
N/A+6.1%$2.20B$211.84M0.00147,000
USA
Liberty All-Star Equity Fund
N/A$6.81
-2.4%
N/A+11.5%$1.84B$355.30M0.00N/ADividend Cut
RVT
Royce Value Trust
N/A$15.62
-0.2%
N/A+15.8%$1.80B$151.28M0.0050
OXLC
Oxford Lane Capital
2.6543 of 5 stars
$5.09
+0.4%
N/A-0.2%$1.76B$194.42M3.64601Upcoming Earnings
Dividend Announcement
BCAT
BlackRock Capital Allocation Term Trust
N/A$15.57
+0.8%
N/A+3.6%$1.67B$211.29M0.00147,000Positive News
GAB
The Gabelli Equity Trust
N/A$5.36
-0.4%
N/A+8.2%$1.62B$147.98M0.00N/ANews Coverage
Positive News
STEW
SRH Total Return Fund
N/A$15.79
flat
N/A+19.9%$1.52B$394.21M0.00N/A
GSBD
Goldman Sachs BDC
1.9323 of 5 stars
$11.87
-0.5%
$13.00
+9.5%
-17.7%$1.39B$90.89M16.96N/APositive News
CET
Central Securities
N/A$44.88
+0.2%
N/A+24.7%$1.27B$300.48M0.006Positive News

Related Companies and Tools


This page (NASDAQ:CCAP) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners